Drug Monograph
Full clinical overview, indications, dosage references & safety notes.
Overview
Dexamethasone (Azium®, Dexasone®) is a potent, long-acting synthetic glucocorticoid used in veterinary medicine to manage inflammation, allergic reactions, immune-mediated diseases, and acute emergency conditions.
It is approximately 30 times more potent than hydrocortisone and has no mineralocorticoid activity. Because its biological action can last more than 48 hours, treatment should always use the lowest effective dose, and tapering is required when used for more than a couple of weeks.
Mechanism of Action (MOA): Dexamethasone suppresses key inflammatory pathways, reduces cytokine production, and decreases immune-cell activation, leading to a rapid reduction in swelling, redness, and immune-driven tissue damage.
Indications
Dexamethasone is used in dogs and cats when strong and rapid suppression of inflammation or immune activity is required. It is often chosen in acute situations or when other corticosteroids are not effective enough. Below are the main clinical situations where dexamethasone is commonly indicated in small animal practice:
- Severe allergic reactions: Useful for acute hypersensitivity, anaphylaxis, post-vaccination reactions, angioedema, and envenomation.
- Inflammatory conditions: Respiratory inflammation (feline asthma-like episodes, bronchitis), dermatologic flare-ups, musculoskeletal inflammation, and gastrointestinal inflammatory episodes such as IBD exacerbations.
- Immune-mediated diseases: Provides fast immunosuppression in IMHA, ITP, autoimmune skin disease, and masticatory myositis.
- Adrenal insufficiency (crisis support): Used during Addisonian crisis because it does not interfere with cortisol testing, making it safe to use before ACTH stimulation tests.
- Neurologic emergencies: Short-term use to reduce intracranial pressure or spinal inflammation when immediate stabilization is needed.
Dosage (Reference)
Dog
Dexamethasone in dogs is mainly used for short-term control of inflammation, immune-mediated flare-ups, or initial stabilization in adrenal crisis due to its strong and long-lasting glucocorticoid effect.
| Clinical use | Route | Dose (mg/kg) | Notes |
|---|---|---|---|
| Anti-inflammatory | PO / IM / IV / SC | 0.07–0.14 | Short courses recommended. |
| Immunosuppressive (IMHA / ITP) | IV | 0.2–0.4 | When oral meds cannot be given. |
| Addisonian crisis | IV | 0.1–0.2 | Safe before ACTH test. |
| Addisonian crisis (alternative) | IV | 0.2–0.5 | For severe collapse. |
Cat
Cats generally require higher mg/kg doses than dogs and may tolerate short-term therapy well. Monitoring is important due to the risk of steroid-induced hyperglycemia.
| Clinical use | Route | Dose (mg/kg) | Notes |
|---|---|---|---|
| Anti-inflammatory | PO / IM / IV / SC | 0.14–0.28 | Standard range. |
| Hypersensitivity dermatitis | PO | 0.2 | Rapid symptomatic relief. |
| Addisonian crisis | IV / IM | 0.1–0.2 | Initial stabilization. |
Dogs:
• LDDS: 0.01 mg/kg IV (samples at 0, 4, 8 hours)
• HDDS: 0.1 mg/kg IV (used when Cushing’s is already confirmed)
Cats:
• LDDS: 0.1 mg/kg IV
• HDDS: 1 mg/kg IV
These doses are for diagnostic evaluation only and are not used for treatment.
Warnings & Precautions
Because dexamethasone has strong and long-lasting glucocorticoid activity, it must be used carefully in patients with systemic disease, risk of ulcers, impaired immunity, or endocrine disorders. The points below summarize the key precautions before and during therapy.
- Systemic fungal infections: Systemic use is contraindicated unless replacing glucocorticoids in Addisonian patients.
- GI ulceration and perforation: Risk is significantly higher when combined with NSAIDs; avoid concurrent use.
- Diabetes mellitus: May cause substantial hyperglycemia, especially in cats; use cautiously and monitor glucose.
- Active or suspected infection: Can mask fever and clinical signs and suppress immune response; use with caution.
- Renal insufficiency: Patients with reduced renal function are more prone to GI complications.
- Long-term therapy: Treatment beyond 2 weeks suppresses the HPA axis; taper gradually to avoid adrenal crisis.
- Ocular effects: Prolonged use (systemic or ophthalmic) may increase intraocular pressure or contribute to cataracts.
- Cats at risk of diabetes: Extra monitoring required due to the stronger hyperglycemic effect in cats.
- Concurrent infections, ulcers, corneal disease: Use cautiously in animals with ulcers, corneal damage, or bacterial infections.
- Stress or surgery during tapering: Animals tapering off dexamethasone may require supplemental steroids during stress.
Drug Interactions
Only a small number of drug interactions with dexamethasone are clinically relevant in dogs and cats. These are the ones most likely to change the drug’s effect or increase the risk of adverse reactions in everyday practice.
- NSAIDs: Major interaction. Combining NSAIDs with corticosteroids greatly increases the risk of gastrointestinal ulceration and perforation—avoid using them together.
- Insulin: Dexamethasone decreases insulin sensitivity and may increase the required insulin dose, especially in diabetic cats. Monitor blood glucose closely.
- Potassium-depleting diuretics (e.g., furosemide): Higher risk of hypokalemia when used together; electrolyte monitoring is recommended.
- Phenobarbital: May reduce dexamethasone effectiveness by increasing hepatic metabolism.
- Azole antifungals (ketoconazole): Can increase dexamethasone blood levels by slowing its metabolism, potentially prolonging effects.
- Modified-live vaccines: Should be avoided in animals receiving immunosuppressive doses of corticosteroids.
Side Effects & Overdose
Side Effects
Most adverse effects appear with repeated or high-dose use, especially in dogs. Cats are generally more tolerant but still require monitoring. The following are the most common clinical signs seen in small-animal practice:
- PU/PD/PP: Very common in dogs during therapy.
- Muscle wasting & weight gain: With prolonged use.
- Delayed wound healing: Due to immune and fibroblast suppression.
- GI irritation / ulcers: Risk increases if combined with NSAIDs.
- Behavior changes: Restlessness, panting, or lethargy (dogs).
- Hyperglycemia: More prominent in cats; monitor diabetic patients.
Overdose
Acute overdose is uncommon but can cause serious gastrointestinal and metabolic complications. Chronic high dosing can mimic severe Cushingoid effects.
- Severe GI bleeding: Hematemesis, melena, abdominal pain.
- Electrolyte disturbances: Mainly hypokalemia.
- Shock or collapse: In cases of massive overdose with GI perforation.
- Management: Aggressive IV fluids, GI protectants, electrolyte correction, and stopping the steroid.
Key Notes
Important points to keep in mind when using dexamethasone in dogs and cats, especially during longer treatment courses or when managing unstable patients:
- Use the lowest effective dose: Dexamethasone has a long biological effect; even small doses can suppress the HPA axis for more than 48 hours.
- Avoid sudden withdrawal: Taper slowly if treatment lasted more than 10–14 days to prevent adrenal suppression and crisis.
- Higher diabetes risk in cats: Cats are more prone to steroid-induced hyperglycemia—monitor glucose closely, especially in overweight or pre-diabetic cats.
- GI complications occur more often in dogs: Dogs are more sensitive to steroid-induced GI ulceration and bleeding; monitor for vomiting, melena, anorexia.
- Do not combine with NSAIDs: The risk of GI perforation increases dramatically when NSAIDs and dexamethasone are used together.
- Monitor electrolytes when combined with diuretics: Hypokalemia may develop, particularly when used with furosemide.
- Be cautious in animals with infections: Dexamethasone can mask clinical signs and reduce immune response—use only when necessary and with proper antimicrobial cover.
- In Addisonian crisis: Dexamethasone is preferred before an ACTH stimulation test because it does not interfere with cortisol measurements.
- Long-term use may cause Cushingoid changes: Muscle wasting, coat changes, potbelly appearance, and behavior changes—mainly in dogs.
- Avoid modified-live vaccines: Especially in patients receiving immunosuppressive doses.




